Maison » Phases of Clinical Trials

Phases of Clinical Trials

1960
Clinical trial setting with researchers discussing drug development processes in pharmacology.

Clinical trials for new drugs are conducted in a structured, multi-phase process. Phase I assesses safety and dosage in a small group of healthy volunteers. Phase II evaluates efficacy and side effects in a larger group of patients. Phase III confirms efficacy, monitors side effects, and compares it to standard treatments in a large patient population before regulatory submission.

The modern clinical trial system is a cornerstone of evidence-based medicine, designed to rigorously test the safety and efficacy of new therapeutic interventions before they are made widely available. The process begins after extensive preclinical research on animals and in vitro models suggests a compound is promising. Phase I trials are the first-in-human studies, typically involving 20-100 healthy volunteers. The primary goal is to determine the drug’s safety profile, including the safe dosage range and identifying acute side effects. Pharmacokinetics (how the body absorbs, distributes, metabolizes, and excretes the drug) is also a key focus. Phase II trials expand the study to several hundred patients who have the condition the drug is intended to treat. This phase aims to provide a preliminary assessment of the drug’s efficacy and to further evaluate its safety. Often, Phase II studies are randomized and include a placebo or standard treatment control group. Phase III trials are large-scale, pivotal studies involving several hundred to several thousand patients. These are typically multi-center, randomized, double-blind, controlled trials designed to provide the definitive evidence of the drug’s efficacy and safety required for regulatory approval. The data gathered in Phase III is used to compare the new drug against existing treatments or a placebo. If successful, the drug sponsor can file a New Drug Application (NDA) with regulatory bodies like the FDA. Phase IV, or post-marketing surveillance, occurs after the drug is approved and on the market. These studies monitor the drug’s long-term safety and effectiveness in a broad, diverse population, and can identify rare or long-term side effects not seen in the earlier, more controlled trials.

UNESCO Nomenclature: 3209
– Pharmacology

Type

Medical Procedure

Disruption

Foundational

Utilisation

Widespread Use

Precursors

  • james lind’s 1747 scurvy trial, one of the first controlled clinical experiments
  • the nuremberg code (1947) establishing ethical principles for human experimentation
  • the declaration of helsinki (1964) providing ethical guidelines for medical research involving human subjects
  • the 1962 kefauver harris amendment to the fd&c act, requiring proof of efficacy

Applications

  • development of all modern prescription drugs
  • approval process for vaccines
  • testing of new medical devices
  • post-market surveillance studies (phase iv)

Brevets :

QUE

Potential Innovations Ideas

!niveaux !!! Adhésion obligatoire

Vous devez être membre de l'association pour accéder à ce contenu.

S’inscrire maintenant

Vous êtes déjà membre ? Connectez-vous ici
Related to: clinical trials, phase i, phase ii, phase iii, drug development, fda, efficacy, safety, pharmacology, new drug application.

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

DISPONIBLE POUR DE NOUVEAUX DÉFIS
Mechanical Engineer, Project, Process Engineering or R&D Manager
Développement de produits efficace

Disponible pour un nouveau défi dans un court délai.
Contactez-moi sur LinkedIn
Plastic metal electronics integration, Design-to-cost, GMP, Ergonomics, Medium to high-volume devices & consumables, Lean Manufacturing, Regulated industries, CE & FDA, CAD, Solidworks, Lean Sigma Black Belt, medical ISO 13485

Nous recherchons un nouveau sponsor

 

Votre entreprise ou institution est dans le domaine de la technique, de la science ou de la recherche ?
> envoyez-nous un message <

Recevez tous les nouveaux articles
Gratuit, pas de spam, email non distribué ni revendu

ou vous pouvez obtenir votre adhésion complète - gratuitement - pour accéder à tout le contenu restreint >ici<

Historical Context

(if date is unknown or not relevant, e.g. "fluid mechanics", a rounded estimation of its notable emergence is provided)

Related Invention, Innovation & Technical Principles

Retour en haut

Vous aimerez peut-être aussi